Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Liuchunyang Yu"'
Publikováno v:
Cell Death and Disease, Vol 15, Iss 8, Pp 1-12 (2024)
Abstract The investigation of aberrations in lipid metabolism within tumor has become a burgeoning field of study that has garnered significant attention in recent years. Lipids can serve as a potent source of highly energetic fuel to support the rap
Externí odkaz:
https://doaj.org/article/c6c22dc524a844038ba8c096295438d8
Autor:
Liuchunyang Yu, Jinxiu Qian, Xiaoxia Xue, Mingshi Pang, Xiangpeng Wang, Xiaoyu Li, Meng Tian, Cheng Lu, Cheng Xiao, Yuanyan Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 179, Iss , Pp 117432- (2024)
Hepatocellular carcinoma (HCC) remains the fourth leading cause of cancer-associated death globally with a lack of efficient therapy. The pathogenesis of HCC is a complex and multistep process, highly reliant on de novo lipogenesis, from which tumor
Externí odkaz:
https://doaj.org/article/1083baa6f6a64d32b41852bcf7473dca
Autor:
Xiaoxia Xue, Xiangpeng Wang, Mingshi Pang, Liuchunyang Yu, Jinxiu Qian, Xiaoyu Li, Meng Tian, Cheng Lu, Cheng Xiao, Yuanyan Liu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Tumors desmoplastic microenvironments are characterized by abundant stromal cells and extracellular matrix (ECM) deposition. Cancer-associated fibroblasts (CAFs), as the most abundant of all stromal cells, play significant role in mediating
Externí odkaz:
https://doaj.org/article/fa78dafa54594e6eb3c0153764e1a453
Autor:
Xiangpeng Wang, Xiaoxia Xue, Mingshi Pang, Liuchunyang Yu, Jinxiu Qian, Xiaoyu Li, Meng Tian, Aiping Lyu, Cheng Lu, Yuanyan Liu
Publikováno v:
MedComm, Vol 5, Iss 8, Pp n/a-n/a (2024)
Abstract Currently, cancer is still a leading cause of human death globally. Tumor deterioration comprises multiple events including metastasis, therapeutic resistance and immune evasion, all of which are tightly related to the phenotypic plasticity
Externí odkaz:
https://doaj.org/article/b844e936e6f74188a531cac992a2ea1f
Autor:
Zixuan Zhao, Zhenglai Hua, Xinyi Luo, Yang Li, Liuchunyang Yu, Ming Li, Cheng Lu, Ting Zhao, Yuanyan Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 150, Iss , Pp 113074- (2022)
Methotrexate (MTX) has been used for the treatment of rheumatoid arthritis (RA) for about forty years and to date MTX remains the part of global standard of treatment for RA. The efficacy of MTX in RA is the result of multiple mechanisms of action. I
Externí odkaz:
https://doaj.org/article/9b355eed62494812b20aa84f69499cb4
Autor:
Wen Li, Zhiwen Cao, Liuchunyang Yu, Qingcai Huang, Dongjie Zhu, Cheng Lu, Aiping Lu, Yuanyan Liu
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-15 (2021)
Abstract Breast cancer (BC) is the most frequently diagnosed cancer with a low survival rate and one of the major causes of cancer-related death. Methotrexate (MTX) is an anti-tumor drug used in the treatment of BC. Poor dispersion in water and toxic
Externí odkaz:
https://doaj.org/article/96e1fe4c8dd446b89e4f6d0df5f09855
Autor:
Chenxi Li, Rui Liu, Yurong Song, Youwen Chen, Dongjie Zhu, Liuchunyang Yu, Qingcai Huang, Zhengjia Zhang, Zeyu Xue, Zhenglai Hua, Cheng Lu, Aiping Lu, Yuanyan Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Rheumatoid arthritis (RA) is a chronic inflammatory disease, characterized by synovial inflammation in multiple joints. Triptolide (TP) is a disease-modifying anti-rheumatic drug (DMARD) highly effective in patients with RA and has anti-inflammatory
Externí odkaz:
https://doaj.org/article/bcc1f8c9ca50414492b751cac85c7302
Autor:
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu, Dongjie Zhu, Yang Li, Zeyu Xue, Zhenglai Hua, Xinyi Luo, Zhiqian Song, Cheng Lu, Ting Zhao, Yuanyan Liu
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Tumor immune escape is a critical step in the malignant progression of tumors and one of the major barriers to immunotherapy, making immunotherapy the most promising therapeutic approach against tumors today. Tumor cells evade immune surveillance by
Externí odkaz:
https://doaj.org/article/e1e20727551647cfb423e89a25da5d4d
Autor:
Chenxi Li, Rui Liu, Yurong Song, Dongjie Zhu, Liuchunyang Yu, Qingcai Huang, Zhengjia Zhang, Zeyu Xue, Zhenglai Hua, Cheng Lu, Yuanyan Liu
Triptolide (TP) is a DMARD highly effective in patients with RA. Hyaluronic acid (HA) hydrogels loaded RGD-attached gold nanoparticles containing TP were synthesized to alleviate the toxicity and increase therapeutic specificity. The hydrogels can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e6751012fe276b274ba4f2f4b1611c7
https://doi.org/10.21203/rs.3.rs-750774/v2
https://doi.org/10.21203/rs.3.rs-750774/v2
Autor:
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu, Dongjie Zhu, Yang Li, Zeyu Xue, Zhenglai Hua, Xinyi Luo, Zhiqian Song, Cheng Lu, Ting Zhao, Yuanyan Liu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2022)
Frontiers in Immunology, Vol 12 (2022)
Tumor immune escape is a critical step in the malignant progression of tumors and one of the major barriers to immunotherapy, making immunotherapy the most promising therapeutic approach against tumors today. Tumor cells evade immune surveillance by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a035dc16bf2e52f95b292b54af6ee5
https://pubmed.ncbi.nlm.nih.gov/35116035
https://pubmed.ncbi.nlm.nih.gov/35116035